This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Who, Where, When, Why, and How.

Lloyd E. King, Jr, MD

Arch Dermatol. 1994;130(12):1545-1547.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

ERYTHRODERMA OR generalized exfoliative dermatitis is a striking but uncommon clinical entity in the practice of most dermatologists. Erythroderma is seen in the neonatal period, but it is most often seen in men over the age of 40 years. Erythroderma, like erythema multiforme and chronic urticaria, is a distinct clinical syndrome caused by multiple factors, some of which are life-threatening. Therefore, dermatologists will be called on to determine what pathogenic factors induced or caused a patient's erythroderma. This Editorial and the article by Botella-Estrada et al1 in this issue of the Archives hopefully provide a useful perspective on erythroderma seen in different clinical settings.

WHO?—IS THE EPIDEMIOLOGY OF ERYTHRODERMA AS UNIFORM AS THE SKIN FINDINGS?

Articles on patients with erythroderma^1-13 all suffer from a common bias, the population selected for evaluation (Figure). If the population was drawn exclusively from dermatology referral centers^1,3,5,13 and compared with that seen by . . . [Full Text PDF of this Article]

Author Affiliations
Division of Dermatology The Vanderbilt Clinic 1301 22nd Ave S Nashville, TN 37232-5227

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?